131 related articles for article (PubMed ID: 30701618)
1. Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant.
Arora R; Haile CN; Kosten TA; Wu Y; Ramakrishnan M; Hawkins LD; Orson FM; Kosten TR
Am J Addict; 2019 Feb; 28(2):119-126. PubMed ID: 30701618
[TBL] [Abstract][Full Text] [Related]
2. Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine.
Haile CN; Kosten TA; Shen XY; O'Malley PW; Winoske KJ; Kinsey BM; Wu Y; Huang Z; Lykissa ED; Naidu N; Cox JA; Arora R; Kosten TR; Orson FM
Am J Addict; 2015 Dec; 24(8):748-55. PubMed ID: 26584468
[TBL] [Abstract][Full Text] [Related]
3. Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine.
Haile CN; Varner KJ; Huijing X; Arora R; Orson FM; Kosten TR; Kosten TA
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146588
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.
Morefield GL; Hawkins LD; Ishizaka ST; Kissner TL; Ulrich RG
Clin Vaccine Immunol; 2007 Nov; 14(11):1499-504. PubMed ID: 17715328
[TBL] [Abstract][Full Text] [Related]
5. A vaccine against methamphetamine attenuates its behavioral effects in mice.
Shen XY; Kosten TA; Lopez AY; Kinsey BM; Kosten TR; Orson FM
Drug Alcohol Depend; 2013 Apr; 129(1-2):41-8. PubMed ID: 23022610
[TBL] [Abstract][Full Text] [Related]
6. Immunological evaluation of chitosan nanoparticles loaded with tetanus toxoid.
Ghalavand M; Saadati M; Ahmadi A; Abbasi E; Salimian J
Bratisl Lek Listy; 2018; 119(2):71-74. PubMed ID: 29455539
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a methamphetamine conjugate vaccine for antibody production in mice.
Stevens MW; Gunnell MG; Tawney R; Owens SM
Int Immunopharmacol; 2016 Jun; 35():137-141. PubMed ID: 27039212
[TBL] [Abstract][Full Text] [Related]
8. Effective active vaccination against methamphetamine in female rats.
Nguyen JD; Bremer PT; Hwang CS; Vandewater SA; Collins KC; Creehan KM; Janda KD; Taffe MA
Drug Alcohol Depend; 2017 Jun; 175():179-186. PubMed ID: 28437722
[TBL] [Abstract][Full Text] [Related]
9. E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant.
Ishizaka ST; Hawkins LD
Expert Rev Vaccines; 2007 Oct; 6(5):773-84. PubMed ID: 17931157
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
Aggerbeck H; Heron I
Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
[TBL] [Abstract][Full Text] [Related]
12. Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: Overcoming the effects of its deficiency with aluminum hydroxide adjuvant.
Lee DK; Lee EY; Kim RH; Kwak HW; Kim JY; Kim H; Kang KW; Lee SM; Park JH; Chang J; Nam JH
Microbiol Immunol; 2018 Mar; 62(3):176-186. PubMed ID: 29315762
[TBL] [Abstract][Full Text] [Related]
13. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
[TBL] [Abstract][Full Text] [Related]
15. The Neurobiology of Methamphetamine Addiction and the Potential to Reduce Misuse Through Conjugate Vaccines Targeting Toll-Like Receptor 4.
Prasad S; Mathew PS; Piper BJ; Kaur K; Tian M
Cureus; 2023 Jun; 15(6):e40259. PubMed ID: 37440809
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
[TBL] [Abstract][Full Text] [Related]
17. Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant.
Syntin P; Piras-Douce F; Dalençon F; Garinot M; Haensler J
Toxicol Appl Pharmacol; 2023 Feb; 460():116358. PubMed ID: 36572229
[TBL] [Abstract][Full Text] [Related]
18. Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE.
Stevens MW; Rüedi-Bettschen D; Gunnell MG; Tawney R; West CM; Owens SM
Drug Alcohol Depend; 2019 Nov; 204():107484. PubMed ID: 31521953
[TBL] [Abstract][Full Text] [Related]
19. Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.
Roeffen W; Theisen M; van de Vegte-Bolmer M; van Gemert G; Arens T; Andersen G; Christiansen M; Sevargave L; Singh SK; Kaviraj S; Sauerwein R
Malar J; 2015 Nov; 14():443. PubMed ID: 26552428
[TBL] [Abstract][Full Text] [Related]
20. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.
Higaki M; Azechi Y; Takase T; Igarashi R; Nagahara S; Sano A; Fujioka K; Nakagawa N; Aizawa C; Mizushima Y
Vaccine; 2001 Apr; 19(23-24):3091-6. PubMed ID: 11312003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
